Citius Oncology CTOR
NASDAQ CTOR
$0.71 -0.04 (-5.22%)
At close: Aug 20, 2026 · 11:49 AM UTC

Citius Oncology (CTOR) Interest Coverage Ratio Growth (1y) (2024 - 2026)

Citius Oncology (CTOR) Interest Coverage Ratio Growth (1y) (2024 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover Growth (1y) (Qtr)
1 Haleon 44.07 Bn 43.10 Bn - -
2 Teva Pharmaceutical Industries 43.41 Bn 39.75 Bn 2.15 Bn -
3 Zoetis 31.83 Bn 30.15 Bn 1.05 Bn -
4 Takeda Pharmaceutical 28.77 Bn 22.97 Bn 5.10 Bn -83.16%
5 United Therapeutics 22.27 Bn 19.61 Bn 683.80 Mn 128.45%
6 Viatris 18.76 Bn 17.87 Bn 1.46 Bn -97.39%
7 Neurocrine Biosciences 15.65 Bn 15.26 Bn 935.80 Mn -
8 Elanco Animal Health 11.93 Bn 11.40 Bn 798.00 Mn -8.29%
9 Dr Reddys Laboratories 10.16 Bn 10.00 Bn - -
10 Citius Oncology 76.95 Mn 76.95 Mn 1.00 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 98.31%
Dec 31, 2025 98.84%
Jun 30, 2025 99.93%
Mar 31, 2025 -5,466.60%
Dec 31, 2024 90.92%